Frontiers in Medical Science Research, 2019, 1(3); doi: 10.25236/FMSR.2019.010308.
Li Feng, Xiao-ru Qin, Yue-xin Wang*, Jia-chen Tang, Song Zhang, Lei Xu
Hebei General Hospital, Shijiazhuang, Hebei Province, Shijiazhuang 050000, China
North China University Of Science And Technology, Tangshan 063000, China
*Corresponding Author
A case of malignant adenomyoepithelioma (MAME) of the breast was analyzed retrospectively. Postoperative pathological examination of immunohistochemical staining of paraffin sections showed that MAME of the breast expressed myoepithelial cellmarkers such as CK5/6, p63, and SMMHC. These results formed the basis of the definitive diagnosis, and the patient was given 4 cycles ofTC chemotherapy. The patient did not have signs of organ recurrence or metastasis after 9 months of follow-up. MAME of the mammary gland is a rare malignant tumor. Detection of the myoepithelial markers by immunohistochemistry is a gold standard for definite diagnosis.
breast; breast malignant tumor; malignant adenomyoepithelioma; myoepithelial markers.
Li Feng, Xiao-ru Qin, Yue-xin Wang, Jia-chen Tang, Song Zhang, Lei Xu. A Case of Malignant Adenomyoepithelioma of the Breast. Frontiers in Medical Science Research (2019) Vol. 1 Issue 3: 60-62. https://doi.org/10.25236/FMSR.2019.010308.
[1] Papazian M, Kalantzis I, Galanopoulos G, et al (2016). Malignant myoepithe lioma of the breast: A case report and review of the literature J. Mol Clin Oncol, vol.4, no.5, pp.723-727.
[2] Yuan Z,Qu X, Zhang ZT, et al (2017). Lessons from managing the breastmalignantadenomyoepi the lioma and the discussion on treatment strategy. World J Oncol, vol.8, no.4, pp.126-131.
[3] Ma B, Yang J (2013). Adenomyelioma of the breast: a case report. Chin J Breast Dis, vol.7, no.2, pp.148-149.
[4] AhmedAA, HellerDS (2000). Malignant adenomyoepithelioma of the breast with malignant proliferation of epithelial and myoepithelial elements: a case report and review of the literature J. Arch Pathol Lab Med, vol.124, no.4, pp.632-636.